Relationships between breast cancer and these medical conditions are biologically plausible, and relevant in terms of public health, yet relatively few epidemiological studies have examined them. Results from studies have been largely null, although, with one exception, 18 confidence intervals (CI) were wide and associations could not be ruled out. 11, 19, 20 Two casecontrol studies of male breast cancer have suggested associations with hyperthyroidism, gallstones, diabetes and high blood cholesterol. 21, 22 The present analyses use data from a large population-based case-control study of breast cancer risk in young women. 23 As part of a detailed administered questionnaire, study subjects were asked about their previous medical history, providing an opportunity to examine associations between various medical conditions and breast cancer in this population.
Materials and Methods
This population-based case-control study was conducted in three geographical areas in the US covered by cancer registries -Atlanta, Seattle/Puget Sound and five counties in central New Jersey. Details have been published elsewhere. 23 Briefly, the present analyses consist of all women aged 20-44 years in Seattle and New Jersey, and aged 20-54 in Atlanta, who were newly diagnosed with in situ or invasive breast cancer during the period 1 May 1990 to 31 December 1992. Cases were identified through rapid ascertainment systems, and controls were chosen through random digit dialling and were frequency matched by geographical area and age to the expected distribution of cases. A 90.5% response rate to the telephone screener was obtained from 16 254 telephone numbers.
Structured face-to-face interviews were carried out, and complete interviews were obtained from 2202 of the 2551 eligible cases (86.3%) and 2009 of the 2571 eligible controls (78.1%). In order for the cases to be comparable with the controls, the 29 cases without residential telephones were excluded from the analyses. The 19 controls who had been previously diagnosed with breast cancer were also excluded from analyses. The study population consisted of the remaining 2173 cases and 1990 controls. Information on risk factors was truncated at the reference date (i.e. date of diagnosis for cases or the date of completion of the telephone screener for controls).
The interview included detailed information on reproductive and menstrual history, contraceptive behaviour and screening history. Subjects were also asked a series of questions on medical history in the period up to one year prior to the reference date, including whether they had ever received a diagnosis by a physician of thyroid disease, gallstones or gallbladder disease, 'sugar' diabetes (not during a pregnancy), polyps in the colon or rectum, high blood pressure (not during a pregnancy), high cholesterol, or a cancer other than that of the breast. For each condition, the year of first diagnosis and the method of treatment (hospitalization, surgery and/or medication) were recorded. Women were defined as having a history of endometriosis or ovarian cysts only if they had undergone surgery for these conditions. Women were defined as postmenopausal if they had either undergone a natural menopause, or surgery to remove both ovaries, or if their ovarian function was unknown but they were older than 51 years (assumed to be the median age of menopause 24 ). Alcohol intake was defined as the lifetime average consumption up to 2 years before reference date.
Odds ratios (OR) and 95% CI were calculated by multiple logistic regression, adjusting for age at reference date as a continuous variable, and the following established or suspected risk factors as categorical variables: race, menopausal status, family history of breast cancer in a first degree relative, previous breast biopsy, a combination variable of number of full-term births and age at first full-term birth, number of mammograms received within the 5-year period prior to one year before reference date, recent body mass index (BMI), average lifetime alcohol consumption, and study site.
Results
The majority of subjects were Ͻ45 years (1647 cases, 1501 controls). There were 526 cases and 489 controls aged 45-54, and these were from Atlanta only. A higher proportion of women in this age group were black (22% of controls aged Ͼ45, compared with 14% of controls aged Ͻ45). However, OR associated with breast cancer risk factors were similar in both age groups (results not shown). Major risk factors were a family history in a first-degree relative, a previous breast biopsy, premenopausal status, low parity, and older age at first full-term birth. There was also some evidence of a relationship between breast cancer risk with BMI, alcohol consumption, and number of mammograms undergone in the previous 5 years. All of the above risk factors were adjusted for in analyses of each medical condition.
Results for thyroid diseases and gallbladder disease are shown in Table 1 . Thyroid disorders as a group were not associated with breast cancer risk (OR = 0.94), although the risk was slightly increased among women who had received surgery (OR = 1.29). There was no significant variation in risk with duration of thyroid disease, type of thyroid disease or menopausal status at the time of breast cancer diagnosis (results not shown). There were insufficient patients to examine treatment effects by type of thyroid disease. A previous study suggested that women diagnosed with any thyroid disease before the age of 20 may be at a higher risk of breast cancer than those diagnosed as adults, 11 but there was no evidence of this in the present study (OR р20 years = 0.82, OR Ͼ20 years = 0.99).
No association was seen between breast cancer and a previous diagnosis of gallstones or gallbladder disease (OR = 1.03, Table 1 ), although the risk was slightly higher among women with a diagnosis of gallbladder disease within the last 5 years (OR = 1.29).
A history of colorectal polyps was associated with a nonsignificantly reduced risk of breast cancer (OR = 0.77, Table 2 ). However, the number of subjects with a history of colorectal polyps was small, and there was no significant variation in risk with type of treatment, time since diagnosis of the polyps, or menopausal status (results not shown). Risk of breast cancer was slightly increased among women with a history of adultonset diabetes (OR = 1.13, Table 2 ). Analyses were restricted to women with onset at age у30 since the vast majority of these cases will have NIDDM. 24 This increased risk was only evident among women who had received medication for their diabetes (OR = 1.39), and among women who had been diagnosed with diabetes 5 or more years prior to breast cancer diagnosis (OR у5 years = 1.38).
No significant association was seen between breast cancer and high blood pressure (OR = 0.86, Table 3 ), although there was a marginally significantly reduced risk among untreated women (OR = 0.72). No significant variation of OR was seen with time since first diagnosis of high blood pressure, or by whether the diagnosis was made pre-or post-menopausally. A previous study suggested that hypertension diagnosed before a last pregnancy has a protective effect on breast cancer, 16 but we saw no evidence for this (OR = 1.04, 95% CI : 0.7-1.5). In contrast, there was a reduced risk among women diagnosed with high blood pressure after the end of their last pregnancy (OR = 0.76, 95% CI : 0.6-1.0).
High cholesterol levels were not associated overall with breast cancer risk (OR = 0.90, 95% CI : 0.7-1.1, Table 3 ). The OR did not vary between those diagnosed with breast cancer pre-and post-menopausally (results not shown). Table 4 shows results of breast cancer risk following surgery for endometriosis or ovarian cysts. There was no overall association with surgery for endometriosis (OR = 1.14). The risk was greater among premenopausal women (OR = 1.68), especially among those with recent surgery (OR 1-9 years = 2.38, 95% CI : 1.0-5.5, results not shown). There was no significant association between breast cancer and surgery for ovarian cysts (OR = 1.16). Oophorectomy is known to reduce the risk of breast cancer, 12 and the women who underwent partial or total oophorectomy as treatment for ovarian cysts had no altered risk of breast cancer (OR = 0.97). In contrast, women with ovarian cysts but no oophorectomy were at an increased risk of breast cancer (OR = 1.94, 95% CI : 1.0-3.9). This risk was particularly elevated among women with a recent surgery (OR 1-9 years = 3.45), although this was based on just six cases and two controls.
Relationships between breast cancer and previous diagnoses of other cancers are shown in Table 5 . There was no significant overall association (OR = 1.11), and the risk did not vary with method of treatment. There was a greater risk among postmenopausal women (OR = 1.76) than among premenopausal women (OR = 1.05). No significant increase in breast cancer risk was associated with any individual cancer site, though there was some evidence of an increased risk with a previous diagnosis of thyroid cancer (OR = 2.04, 10 cases), basal cell carcinoma (OR = 2.01, 14 cases), Hodgkin's disease (OR = 1.80, 11 cases) and malignant melanoma (OR = 1.35, 16 cases, results not shown). However, the numbers of events were small and lacked power to detect a significantly increased risk. There was no evidence of an increased risk of breast cancer following diagnoses of cancer of the cervix, uterus or ovary.
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Discussion
The largely null results in this study support previous studies, 11, [18] [19] [20] and provide further reassurance that young women with these conditions are not at an increased risk of breast cancer. The study is large and has the advantage of being population-based rather than hospital-based. However, the young age range results in few women with some of the medical conditions under study, and true associations with breast cancer may therefore not have been detected. Further, the study was designed to assess breast cancer risk in relation to oral contraceptive use, and questions on medical history were relatively brief. A potential source of bias is that medical history is defined as self-reported physician-diagnosed disease and was not verified. However, it has been shown that self-reporting of most chronic conditions (including thyroid diseases, diabetes, gallbladder disease, hypertension, and cancer), and recall of prior hospitalization and surgery is reasonably accurate, [25] [26] [27] although self-reported high cholesterol may be less so. 28 It is possible that non-differential misclassification may have contributed to the null findings. Any bias due to cases recollecting medical history more completely than controls would tend to increase relative risks, 29 and would not explain the null results observed.
Despite clinical observations of thyroid disease in breast cancer patients, 4 there is little epidemiological support for an association. 4, 18, 19, 30, 31 Details of the types of medication used for treatment of thyroid disease were not available in our study, and it is possible that treatment of hyperthyroidism with radioactive iodine 131 I may be associated with an increased risk of breast cancer, but evidence for this is not conclusive. 4, 11, 32 Our results provide further evidence that young women with thyroid disease are at no altered risk of breast cancer.
Both gallbladder disease and breast cancer are more prevalent in females than in males, and also in developed countries, possibly suggesting common hormonal and dietary risk factors. 6 Increased risks of cancers of the breast, reproductive system and gastrointestinal tract in women with gallstone disease aged Ͻ50 have been seen, 33 but our results support most other studies in finding no association. 11, [18] [19] [20] 34, 35 Colorectal adenomatous polyps are precursor lesions for most colorectal cancers, 36 and several studies have found an association between breast and colorectal cancers, suggesting shared risk factors. 14, 15 Two studies found an increased prevalence of colorectal polyps in breast cancer cases compared with hospital controls 37,38 but our null finding supports more recent work. 39, 40 Breast cancer shares several risk factors with NIDDM, including increased prevalence in females compared with males, central obesity (for postmenopausal women), and, possibly, a protective effect of physical activity. 41 Insulin is an important growth factor for human breast cancer cells cultured in vitro 8 and it is interesting to note that significant associations with breast cancer risk have been noted with serum C-peptide levels 42 (an accurate estimate of insulin secretion) and with circulating concentrations of insulin-like growth factor. 43 In most investigations, however, no association has been seen between breast cancer and diabetes, 11, 19, 21, 44, 45 although a recent study did support a modest elevation in risk for postmenopausal breast cancer. 18 The lack of an association for the most part could be due to the natural history of NIDDM, which is characterized by hyperinsulinaemia in early stages, followed by hypoinsulinaemia as the disease progresses. 46 The slightly reduced breast cancer risk associated with a previous diagnosis of high blood pressure did not vary with menopausal status, in contrast to two other studies where a history of high blood pressure was associated with a reduced risk of breast cancer in premenopausal women, but an increased risk in postmenopausal women. 19, 20 In the present study, there was no evidence of an increased risk associated with use of medications, contrasting with studies from the 1970s that suggested that reserpine was associated with breast cancer, a relationship that has not been subsequently confirmed. 17 One study of women aged under 55 found a significantly reduced risk of breast cancer among parous women whose high blood pressure was diagnosed prior to the end of their most recent pregnancy. 16 However, this result was not supported in a larger study, 19 or in the present study.
Several cohort studies have found no association between breast cancer risk and total serum cholesterol, [47] [48] [49] [50] although in one study higher cholesterol levels were associated with a significantly lower risk of breast cancer among women aged under 50. 51 The slightly reduced risk seen in the present study is likely to be due to chance, but possibly also to the cholesterollowering effect of the preclinical cancer, 17, 52 as the reduction was seen only among women with a recent diagnosis of high cholesterol. Our study is limited by the lack of biological samples and by the self-reported history of high cholesterol, which was largely untreated.
Both endometriosis and ovarian cysts are associated with increased levels of ovarian hormones. 9, 10 The suggested increased breast cancer risk among premenopausal women in this study following surgery for endometriosis supports findings from several previous studies. 11, 53 The extent to which this relationship is biological or due to shared risk factors remains unclear. Breast cancer and ovarian cysts also share risk factors such as nulliparity, early age at menarche and late age at first birth, 10 but previous studies have not found an association between breast cancer and ovarian cysts among premenopausal women, 11, 18, 19 possibly because of the inclusion of women who had undergone an oophorectomy.
No significant association between breast cancer and a history of a previous cancer was seen in this study. However, numbers are small and the data are consistent with previously observed associations between breast cancer and malignant melanoma, thyroid cancer and Hodgkin's disease. 13, 54, 55 Oestrogen receptors have been found in malignant melanoma cells, suggesting that oestrogens may be involved in the aetiology. 13 The increased risk of breast cancer following Hodgkin's disease may be a treatment effect of radiotherapy or chemotherapy, 55 although an increased risk has also been seen among the few patients receiving neither radiotherapy nor chemotherapy. 54 The present study is too small to evaluate the effect of treatment for other cancers on subsequent breast cancer risk. Ovarian cancer and breast cancer share several risk factors such as nulliparity and late age at menopause, and the observed OR associated with ovarian cancer (OR = 1.21) may be an underestimate, as the three cases and three controls each underwent surgery for ovarian cancer, which would reduce the risk of breast cancer. 12 To conclude, our generally null results from this large, population-based study support results from previous studies in providing reassurance that women with a history of several common medical conditions do not appear to be at an increased risk of breast cancer at a young age. Many of these conditions, however, were relatively rare among our younger study subjects. Given that many of these conditions could potentially be biologically related to subsequent breast cancer risk, future studies should continue to investigate effects among older women. f Among women without an oophorectomy only. Excludes two cases with unknown year of diagnosis.
g Only two postmenopausal women (one case and one control) with ovarian cysts had not had an oophorectomy.
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